Weesp, Netherlands

Willy Deleersnijder

This inventor holds 8 USPTO granted patents. Top assignees: Solvay Pharmaceuticals, B.v., Solvay Pharmaceuticals, Gmbh. Active years: 2005-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Willy Deleersnijder. Retrieved from https://idiyas.com/inventor/willy-deleersnijder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 37.5

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Weesp, BE (2007)
  • Weesp, NL (2005 - 2008)

Company Filing History:


Years Active: 2005-2008

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Willy Deleersnijder: Innovator in G-Protein Coupled Receptors

Introduction

Willy Deleersnijder is a prominent inventor based in Weesp, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of G-protein coupled receptors. With a total of 8 patents to his name, his work has advanced our understanding of these critical biological systems.

Latest Patents

Deleersnijder's latest patents include groundbreaking inventions related to the G-protein coupled receptor family. One notable patent is for a binding assay employing IGS4, which involves novel identified polynucleotides and polypeptides. This invention focuses on the inhibition or activation of these polynucleotides and polypeptides, as well as methods for screening compounds that act as agonists or antagonists of the IGS family. Another significant patent involves a polynucleotide and expression system for a novel human G-protein coupled receptor, also related to the IGS4 family. Both patents highlight the high affinity binding of neuropeptides known as neuromedin U to the IGS4 polypeptides.

Career Highlights

Throughout his career, Willy Deleersnijder has worked with notable companies such as Solvay Pharmaceuticals, B.V. and Solvay Pharmaceuticals, GmbH. His experience in these organizations has allowed him to collaborate on various innovative projects that have contributed to advancements in pharmaceutical research and development.

Collaborations

Deleersnijder has collaborated with several professionals in his field, including Rico Wiegers and Michael Weske. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Willy Deleersnijder's contributions to the field of G-protein coupled receptors have made a lasting impact on biotechnology. His patents and collaborations reflect his dedication to advancing scientific knowledge and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…